lipoxin a4 has been researched along with pobilukast in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Badr, KF; DeBoer, DK; Schwartzberg, M; Serhan, CN | 1 |
Brady, HR; Godson, C; Martin, F; McMahon, B; Mitchell, D; Shattock, R | 1 |
2 other study(ies) available for lipoxin a4 and pobilukast
Article | Year |
---|---|
Lipoxin A4 antagonizes cellular and in vivo actions of leukotriene D4 in rat glomerular mesangial cells: evidence for competition at a common receptor.
Topics: Animals; Binding, Competitive; Dicarboxylic Acids; Dose-Response Relationship, Drug; Glomerular Filtration Rate; Glomerular Mesangium; Hydroxyeicosatetraenoic Acids; Inositol 1,4,5-Trisphosphate; Inositol Phosphates; Lipoxins; Rats; Receptors, Immunologic; Receptors, Leukotriene; Renal Circulation; SRS-A | 1989 |
Lipoxin, leukotriene, and PDGF receptors cross-talk to regulate mesangial cell proliferation.
Topics: Animals; Cell Division; Cells, Cultured; CHO Cells; Cricetinae; Dicarboxylic Acids; Enzyme Inhibitors; Glomerular Mesangium; Humans; Hydroxyeicosatetraenoic Acids; Indoles; Leukotriene Antagonists; Leukotriene D4; Lipoxins; Maleimides; Phosphorylation; Protein Kinase C; Receptor Cross-Talk; Receptors, Cell Surface; Receptors, Leukotriene; Receptors, Platelet-Derived Growth Factor; Tyrosine | 2002 |